{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:56:49Z","timestamp":1791295009222,"version":"4.1.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:00:00Z","timestamp":1426204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003588","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T14:16:07Z","timestamp":1426256167000},"page":"e0003588","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":111,"title":["Targeting Ergosterol Biosynthesis in Leishmania donovani: Essentiality of Sterol 14alpha-demethylase"],"prefix":"10.1371","volume":"9","author":[{"given":"Laura-Isobel","family":"McCall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amale","family":"El Aroussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora F.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"De Muylder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Kellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair L.","family":"Siqueira-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Roush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa M.","family":"Podust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"McKerrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"HW Murray","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pt.2014.05.001","article-title":"Determinants of disease phenotype in trypanosomatid parasites","volume":"30","author":"LI McCall","year":"2014","journal-title":"Trends in Parasitology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1003053","DOI":"10.1371\/journal.ppat.1003053","article-title":"Determinants for the development of visceral leishmaniasis disease","volume":"9","author":"LI McCall","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"P Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis Worldwide and Global Estimates of Its Incidence","volume":"7","author":"J Alvar","year":"2012","journal-title":"Plos One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"PJ Hotez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India","volume":"362","author":"S Sundar","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e2613","DOI":"10.1371\/journal.pntd.0002613","article-title":"Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome(R) for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial","volume":"8","author":"EA Khalil","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s40265-013-0133-0","article-title":"Therapeutic options for visceral leishmaniasis","volume":"73","author":"B Monge-Maillo","year":"2013","journal-title":"Drugs"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/156802611796575902","article-title":"Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis","volume":"11","author":"GI Lepesheva","year":"2011","journal-title":"Current topics in medicinal chemistry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"642502","DOI":"10.1155\/2009\/642502","article-title":"Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs","volume":"2009","author":"W de Souza","year":"2009","journal-title":"Interdisciplinary perspectives on infectious diseases"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"26838","DOI":"10.1074\/jbc.M111.237099","article-title":"Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum","volume":"286","author":"TY Hargrove","year":"2011","journal-title":"J Biol Chem"},{"key":"ref13","article-title":"Drug Strategies Targeting CYP51 in Neglected Tropical Diseases","author":"JY Choi","year":"2014","journal-title":"Chemical Reviews"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1004427","DOI":"10.1371\/journal.ppat.1004427","article-title":"Sterol Biosynthesis Is Required for Heat Resistance but Not Extracellular Survival in Leishmania","volume":"10","author":"W Xu","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"R Reithinger","year":"2007","journal-title":"The Lancet infectious diseases"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/infdis\/145.2.279","article-title":"In vitro susceptibility of antimony-resistant Leishmania to alternative drugs","volume":"145","author":"JD Berman","year":"1982","journal-title":"The Journal of infectious diseases"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/jac\/32.6.837","article-title":"The in-vitro anti-leishmanial activity of inhibitors of ergosterol biosynthesis","volume":"32","author":"A Gebre-Hiwot","year":"1993","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0166-6851(88)90166-1","article-title":"Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes","volume":"31","author":"DH Beach","year":"1988","journal-title":"Molecular and Biochemical Parasitology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/AAC.43.12.2910","article-title":"Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases","volume":"43","author":"HM Al-Abdely","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.43.1.172","article-title":"Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum","volume":"43","author":"JP Gangneux","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-6851(89)90026-1","article-title":"Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages","volume":"33","author":"DT Hart","year":"1989","journal-title":"Molecular and Biochemical Parasitology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0166-6851(86)90145-3","article-title":"Effects of Ketoconazole on Sterol Biosynthesis by Leishmania-Mexicana Mexicana Amastigotes in Murine Macrophage Tumor-Cells","volume":"20","author":"JD Berman","year":"1986","journal-title":"Molecular and Biochemical Parasitology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2307\/3282158","article-title":"In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents","volume":"73","author":"JD Berman","year":"1987","journal-title":"The Journal of parasitology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0166-6851(85)90089-1","article-title":"Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes","volume":"15","author":"LJ Goad","year":"1985","journal-title":"Molecular and Biochemical Parasitology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.exppara.2012.06.001","article-title":"Involvement of the Leishmania donovani virulence factor A2 in protection against heat and oxidative stress","volume":"132","author":"LI McCall","year":"2012","journal-title":"Exp Parasitol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkp851","article-title":"TriTrypDB: a functional genomic resource for the Trypanosomatidae","volume":"38","author":"M Aslett","year":"2010","journal-title":"Nucleic Acids Research"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-2958.2009.06610.x","article-title":"Methylene tetrahydrofolate dehydrogenase\/cyclohydrolase and the synthesis of 10-CHO-THF are essential in Leishmania major","volume":"71","author":"SM Murta","year":"2009","journal-title":"Mol Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0166-6851(03)00079-3","article-title":"Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania","volume":"128","author":"KA Robinson","year":"2003","journal-title":"Molecular and Biochemical Parasitology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0166-6851(93)90231-L","article-title":"Rapid Isolation of DNA from Trypanosomatid Protozoa Using a Simple Mini-Prep Procedure","volume":"59","author":"E Medinaacosta","year":"1993","journal-title":"Molecular and Biochemical Parasitology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1101\/gr.123430.111","article-title":"Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance","volume":"21","author":"T Downing","year":"2011","journal-title":"Genome Research"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2958.2010.07229.x","article-title":"Localization and induction of the A2 virulence factor in Leishmania: evidence that A2 is a stress response protein","volume":"77","author":"LI McCall","year":"2010","journal-title":"Mol Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1736","DOI":"10.1371\/journal.pntd.0001736","article-title":"Diverse inhibitor chemotypes targeting Trypanosoma cruzi CYP51","volume":"6","author":"SS Gunatilleke","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/ml500010m","article-title":"R-Configuration of 4-Aminopyridyl-Based Inhibitors of CYP51 Confers Superior Efficacy Against Trypanosoma cruzi","volume":"5","author":"JY Choi","year":"2014","journal-title":"Acs Medicinal Chemistry Letters"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1021\/jm401067s","article-title":"Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents","volume":"56","author":"JY Choi","year":"2013","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1021\/jm500448u","article-title":"4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency","volume":"57","author":"CM Calvet","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1101\/gr.122945.111","article-title":"Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania","volume":"21","author":"MB Rogers","year":"2011","journal-title":"Genome Research"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e1001868","DOI":"10.1371\/journal.pbio.1001868","article-title":"Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasite leishmania","volume":"12","author":"JM Ubeda","year":"2014","journal-title":"PLoS biology"},{"key":"ref39","article-title":"Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses","author":"M Dacher","year":"2014","journal-title":"Mol Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e2646","DOI":"10.1371\/journal.pntd.0002646","article-title":"LmaPA2G4, a Homolog of Human Ebp1, Is an Essential Gene and Inhibits Cell Proliferation in L. major","volume":"8","author":"B Norris-Mullins","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1128\/AAC.00311-07","article-title":"Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography","volume":"51","author":"LM Podust","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cbic.201402027","article-title":"Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-Aminopyridyl-based sulfonamide derivatives","volume":"15","author":"DF Vieira","year":"2014","journal-title":"Chembiochem: a European journal of chemical biology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1371\/journal.pntd.0000372","article-title":"Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit","volume":"3","author":"CK Chen","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1128\/AAC.00281-10","article-title":"A nonazole CYP51 inhibitor cures Chagas\u2032 disease in a mouse model of acute infection","volume":"54","author":"PS Doyle","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbapap.2010.06.006","article-title":"Structural basis for conservation in the CYP51 family","volume":"1814","author":"GI Lepesheva","year":"2011","journal-title":"Biochimica Et Biophysica Acta"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.febslet.2014.08.030","article-title":"Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition","volume":"588","author":"TS Cherkesova","year":"2014","journal-title":"Febs Letters"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00436-013-3274-x","article-title":"Voriconazole suppresses the growth of Leishmania species in vitro","volume":"112","author":"MM Kulkarni","year":"2013","journal-title":"Parasitology Research"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/AAC.01498-10","article-title":"Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole","volume":"55","author":"AE Paniz Mondolfi","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1128\/AAC.40.12.2785","article-title":"Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes","volume":"40","author":"H Rangel","year":"1996","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"37723","DOI":"10.1074\/jbc.274.53.37723","article-title":"Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression\/selection","volume":"274","author":"PC Cotrim","year":"1999","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1016\/j.bmc.2005.02.060","article-title":"Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa","volume":"13","author":"SO Lorente","year":"2005","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1128\/AAC.48.8.2937-2950.2004","article-title":"Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis","volume":"48","author":"SO Lorente","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.micpath.2013.11.001","article-title":"Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies","volume":"66","author":"N Dinesh","year":"2014","journal-title":"Microbial Pathogenesis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/gb-2004-5-11-248","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases","volume":"5","author":"JA Friesen","year":"2004","journal-title":"Genome biology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e25273","DOI":"10.1371\/journal.pone.0025273","article-title":"CYP5122A1, a novel cytochrome P450 is essential for survival of Leishmania donovani","volume":"6","author":"S Verma","year":"2011","journal-title":"Plos One"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0031182099006125","article-title":"The vectorial competence of Phlebotomus sergenti is specific for Leishmania tropica and is controlled by species-specific, lipophosphoglycan-mediated midgut attachment","volume":"121","author":"S Kamhawi","year":"2000","journal-title":"Parasitology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0166-6851(91)90150-5","article-title":"Substrate-dependent pH optima of gp63 purified from seven strains of Leishmania","volume":"47","author":"AK Tzinia","year":"1991","journal-title":"Molecular and Biochemical Parasitology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2032 disease","volume":"370","author":"I Molina","year":"2014","journal-title":"The New England journal of medicine"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T20:05:11Z","timestamp":1566417911000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003588"}},"subtitle":[],"editor":[{"given":"Alain","family":"Debrabant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,13]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003588","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,13]]}}}